arrow
H

Hussein Al-Mossawi

immunocore ltd.
H指数:21
被引数:2,260

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term effect of anifrolumab on patient-reported outcomes in systemic lupus erythematosus (TULIP-LTE): a randomised, placebo-controlled, phase 3 long-term extension trial

阿尼夫罗鲁单抗对系统性红斑狼疮患者报告结局的长期影响(TULIP-LTE):一项随机、安慰剂对照、III期长期扩展试验

2025-05-020
PRE
LLDAS and remission attainment with anifrolumab treatment in patients with systemic lupus erythematosus: results from the TULIP and long-term extension randomised controlled trialsI

LLDAS与安尼福卢单抗治疗系统性红斑狼疮患者中缓解的达成:来自TULIP和长期扩展随机对照试验的结果

2025-01-010
PRE
A Randomized, Placebo-Controlled Phase III Extension Trial of the Long-Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus

Anifrolumab在活动性系统性红斑狼疮中的长期安全性和耐受性的随机,安慰剂对照的III期扩展试验

2022-11-1167
OA
Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis

单细胞测序揭示了银屑病关节炎中表达组织归巢受体的促炎性滑膜CD8 T细胞的克隆扩增

2020-09-21117
OAAI